gastroesophageal reflux. gastroesophageal reflux without esophagitis
Conditions
Interventions
Intervention 1: Case group1: S. hortensis capsules (one capsule three times a day for 4 weeks, before meal). Intervention 2: Placebo capsules (one capsule three times a day for 4 weeks, before meal).
Treatment - Drugs
Placebo
Case group1: S. hortensis capsules (one capsule three times a day for 4 weeks, before meal)
Placebo capsules (one capsule three times a day for 4 weeks, before meal)
Sponsors
Colorectal Research Center,Rasoul Akram Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having the classic symptoms of reflux, patients with 18 to 65 years old, the normal examination by a gastroenterologist Exclusion criteria: smoking, ongoing alcohol users, OB positive, risk of peptic ulcer or cancer, pregnant women, breast feeding women, any digestive disorder which requires new protocols, significant surgical or medical disorders clinically, hospitalization, and do not use of S. hortensis capsules for 2 weeks.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reflux symptoms. Timepoint: before intervention and four weeks after starting the intervention. Method of measurement: visual analogue scale, frequency scale for symptoms of gastroesophageal reflux disease. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhazaleh Heydarirad
Colorectal Research Center, Rasoul Akram Hospital
Outcome results
None listed